Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAMACS: CSII vs MDI in Type 2 Diabetes
NCT01574508Phase 4Unknown
- Sponsor
- Shanghai Jiao Tong University School of Medicine
- Start
- Dec 2011
- Primary completion
- Dec 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of human insulin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Shanghai Jiao Tong University School of Medicine. Primary endpoints: Glycated hemoglobin at 1 year and Glycated albumin at 1 year. Status: unknown.
02
Drugs
human insulin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01574508.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01574508.